Behaviorally Enhanced Counseling on Nicotine Dependence (BEACON) Trial.
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The major purpose of this exploratory developmental study will be to develop a
patient-centered and feasible protocol for communicating genetic data as it relates to drug
efficacy for smoking cessation inpatients receiving medication that is matched to individual
genotypes associated with increased efficacy for bupropion or nicotine replacement therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Stanford University
Collaborators:
Johns Hopkins University National Institute on Drug Abuse (NIDA) SRI International University of Bristol